Lipocine Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. The company's lead product candidate, TLANDO, is an oral testosterone replacement therapy for testosterone deficiency. Lipocine was founded in 2013 and is headquartered in Salt Lake City, Utah.